Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneOral versus intravenous steroids for treatment of relapses in multiple sclerosisCorticosteroids for the long-term treatment in multiple sclerosisClinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case seriesOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionMultiple sclerosisEpigenetic Drugs for Multiple SclerosisPathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathwaysA phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairmeTherapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axisAdrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trialManagement of acute exacerbations in multiple sclerosis.Drug therapy for multiple sclerosis.ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) RegistryFive-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.A predictive model for corticosteroid response in individual patients with MS relapsesImmune mediated diseases and immune modulation in the neurocritical care unitQuantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosisAssessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Repeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a review.Multiple sclerosis treatment and infectious issues: update 2013.Outcome of MS relapses in the era of disease-modifying therapy.Corticosteroids in the management of acute multiple sclerosis exacerbations.Multiple Sclerosis: Immunopathology and Treatment Update.Lipid synthesis and secretion in HepG2 cells is not affected by ACTH.Melanocortins, Melanocortin Receptors and Multiple Sclerosis.Reducing costs while enhancing quality of care in MS.The clock keeps ticking for intravenous methylprednisolone.Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.Coexistence of systemic lupus erythematosus and multiple sclerosis. A case report and literature review.
P2860
Q21558407-BEB6A3ED-06B9-4253-A214-2D2AD49C9D60Q24202564-C5877374-F196-473C-B929-621BB6CDC5E9Q24242150-53F59477-08D1-40DB-8E4D-600C8A5BE1E5Q26748598-D86DB729-18E3-4C23-8376-250F95B4CE32Q26822611-953AE7E0-BBD8-48F8-A226-859A6B825750Q26995437-B0E0633A-D2BA-4969-98F7-0E5649BC89BDQ28076395-B20136A6-8046-46BB-B25B-C565DC17C864Q28235168-79829C3D-9ABF-4D6E-83D5-CA5F951E0649Q28477712-0C00D694-246B-4841-89F8-50E61EE640F6Q30354658-AF4FC397-DB9C-496C-B84D-B69A372A0207Q30849102-7D7586F7-9BAC-43C6-BD27-F15C485DAF38Q31023281-5F7DF80D-C5C5-4CFF-A0C7-E464A800333BQ33575275-0EB77B96-CAA1-4979-964F-15F6193F0A7DQ33589934-084CA517-5E58-45F8-85D5-A383484DB852Q33670934-AE10D391-259B-4572-8898-DA7A050195E7Q33990246-2DE38FBD-A2C0-4CCB-B967-C7FDB1CC41A7Q34969795-0EA21CFA-674F-4513-BC18-2342E6B491B0Q34982119-0006C018-5442-4D0E-B09E-72214A61406FQ35117806-FB1349CA-80C2-4840-BFCB-E86612C1D24DQ35192482-882D5D36-1951-4B16-A082-E9A221A21985Q35729575-6A622A05-76F2-469B-ADBB-D66771FECCF8Q35811145-FCD2534B-F751-490B-AA31-0EB4A5D2E5E3Q36015388-AA1FE323-511A-4929-84D3-F845D4A5BCC9Q36143008-38153F0C-34AC-46EE-8D5F-171CC2F72CECQ36915999-3923D822-CE0C-46BF-95A0-D1201A7D8CB0Q37052797-2E9E656A-4AE5-4D85-BC39-209CE00AE5EAQ37442240-8B05FE8B-37A8-47FF-AD0C-087E5ED0E398Q37599583-6AD9B131-DF87-474D-96A2-6A71624E7779Q37638947-E538BE79-69BC-45DC-B1F5-4ED3E4F0618EQ37957891-1C9492CB-2B9E-428B-BE57-A635FF99BF08Q38153471-EE04032E-8EAE-470B-A875-7FF1B093A81BQ38636590-61981CC2-1C05-44C7-9676-CC090DBB574FQ39229363-F96C3E30-F806-4FE7-89C8-B1347DA466F8Q39420793-1CA2C556-D75F-411C-A3C2-127587027944Q39703162-53567EE9-67AF-4D74-B2E3-83722BAD5A59Q41552761-194C016C-1CF7-4808-A15A-C7CEBB329A99Q41966640-EAA84026-3D24-4EA0-8A9D-9B1132448351Q42765791-38FE94B8-4929-45A2-83B4-2A9CB377F141Q47158177-4C726BA5-74C9-4F46-830C-8B935087963EQ52584318-85CF4405-457F-476D-A96A-62D9F3F4DB71
P2860
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@ast
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@en
type
label
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@ast
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@en
prefLabel
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@ast
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@en
P2093
P2860
P1476
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
@en
P2093
A Citterio
F Brusaferri
G Filippini
L Candelise
W A Sibley
P2860
P304
P356
10.1002/14651858.CD001331
P577
2000-01-01T00:00:00Z